Skip to search.
 TSX Down 0.04% TSX Ventures Up 0.83%

Eli Lilly and Company (LLY)

-NYSE
70.17 Up 0.14(0.20%) Feb 27, 4:00PM EST
|After Hours : 70.19 Up 0.02 (0.03%) Feb 27, 5:03PM EST
Add to Portfolio
Prev Close:70.03
Open:69.95
Bid:69.31 x 100
Ask:70.20 x 100
1y Target Est:75.06
Beta:0.47
Next Earnings Date:23-Apr-15LLY Earnings announcement
Day's Range:69.91 - 70.50
52wk Range:56.81 - 75.10
Volume:3,353,235
Avg Vol (3m):4,687,700
Market Cap:74.42B
P/E (ttm):31.47
EPS (ttm):2.23
Div & Yield:2.00 (2.90%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
LLYUp 0.20%74.42B
GSKDown 0.88%114.07B
PFEDown 0.78%216.24B
SNYDown 0.02%128.58B

Key Statistics

Forward P/E (1 yr):19.55
P/S (ttm):3.79
Ex-Dividend Date:11-Feb-15

Analysts

Annual EPS Est (Dec-15) :3.16
Quarterly EPS Est (Mar-15) :0.76
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):5.47

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates in two segments, Human Pharmaceutical Products and Animal Health products. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback